QMedic reports a $2,000 Medicare drug cost cap starting in 2026, ensuring predictable spending and potentially avoiding ...

Quantum computing is a paradigm shift poised to redefine problem-solving, innovation, and competitive landscapes.

In particular, Konagurthu says, AI/ML can help sift through a field of drug candidates in which the percentage that are ...

The Centers for Medicare & Medicaid Services (“CMS”) recently finalized a Medicare payment rule with significant implications for life ...

What began with approvals, letters and public money ended with silence from the very officials who enabled the Drug User ...

On November 6, 2025, the Centers for Medicare & Medicaid Services (CMS) issued a press release announcing the voluntary “GENErating cost ...

For the better part of the last three years, artificial intelligence (AI) has been the driving trend on Wall Street.

Explore why Prospect Capital (PSEC) trades at a deep discount, its dividend risks, and what investors should know before ...

Health Canada recently approved lecanemab (brand name Leqembi®) to treat people with mild cognitive impairment or mild dementia due to Alzheimer’s disease. This is the first approved drug that is ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

Using the 2 Stage Free Cash Flow to Equity, Webjet Group fair value estimate is AU$1.39 Webjet Group's AU$0.72 share price signals that it might be 48% undervalued The AU$1.02 analyst price target for ...

Just as airline deregulation in 1978 ended the need for costly travel agents and slashed airfares, Medicare transparency can ...